Senate Committee Passes Kennedy's FDA Budget Increase Amendment

Article

ePT--the Electronic Newsletter of Pharmaceutical Technology

The US Senate passed an amendment to the fiscal year 2009 budget bill that will increase the amount allotted to FDA by $71 million, bringing the agency's total FY 2009 budget increase to $375 million.

Washington, DC (Mar. 13)-The US Senate passed an amendment to the fiscal year (FY) 2009 budget bill that will increase the amount allotted to the US Food and Drug Administration by $71 million, bringing the agency’s total FY 2009 budget increase to $375 million. Senator Edward M. Kennedy (D–MA), Chairman of the Health, Education, Labor and Pensions Committee, proposed the amendment to the Senate Budget Committee’s increase of $304 million to include an additional $71 million.

In a summary of the amendment posted on his website, Kennedy cited FDA’s insufficient funds, outdated information technology systems, and the need for inspections of foreign food and drug facilities as reasons for the budget increase.

“When American families go to the grocery store, they shouldn’t have to worry about the safety of the food they buy,” Kennedy said on his website. “When they are prescribed a drug, they shouldn’t have to worry that a contaminant in the drug might kill them. They ought to be able to count on FDA to stand guard for them, use the latest and best science to protect them, and to do what’s needed to detect dangerous products.”

 

Recent Videos
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content